Compare ACON & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACON | ISPC |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 3.8M |
| IPO Year | N/A | 2020 |
| Metric | ACON | ISPC |
|---|---|---|
| Price | $3.37 | $4.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 133.1K | ★ 29.8M |
| Earning Date | 05-14-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | $87.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.34 | $0.10 |
| 52 Week High | $12.03 | $2.16 |
| Indicator | ACON | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 97.93 |
| Support Level | $3.00 | $0.40 |
| Resistance Level | $3.56 | N/A |
| Average True Range (ATR) | 0.29 | 0.09 |
| MACD | -0.01 | 0.29 |
| Stochastic Oscillator | 39.18 | 87.25 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.